AKT1 and prostate carcinoma: Recent studies have demonstrated that Plk1 has a cell cycle–independent function in the regulation of EMT by activating CRAF/ERK signaling in prostate cancer (Wu et al, 2016b) or by activating AKT in gastric cancer (Cai et al, 2016).